Patent · US Active

Pain treatment

US9834599B2 · kind B2 · utility

0Cited by

9References

18Claims

0Family size

Assignee

The University of Melbourne · AU

Inventors

John Allan Hamilton · Melbourne, AU
Andrew David Cook · Melbourne, AU

Key dates

Filing date	Apr 29, 2016
Grant date	Dec 5, 2017
Priority date	—
Expiry date	Apr 29, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates generally to a method for the treatment and prophylaxis of pain. In accordance with the present invention, it is proposed that antagonists of GM-CSF are effective in the treatment of pain. Antagonists of GM-CSF include, but are not limited to, antibodies which are specific for GM-CSF or the GM-CSF receptor. The present invention further provides transgenic animals, such as a GM-CSF knock-out mouse, useful for testing antagonists in certain disease models.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.